Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Nevro Corp (NVRO) USD0.001

Sell:$104.66 Buy:$104.73 Change: $0.46 (0.44%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$104.66
Buy:$104.73
Change: $0.46 (0.44%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$104.66
Buy:$104.73
Change: $0.46 (0.44%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain. HF10 therapy enables patients to achieve sustained pain relief without paresthesia, thus enabling its patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia. HF10 therapy relies on consistent anatomical lead placement. As of December 31, 2016, it was investigating the use of HF10 therapy to address additional indications, such as chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. The Senza system is approved to create electrical impulses from 2 hertz (Hz) to 10,000 Hz.

Contact details

Address:
1800 Bridge Pkwy
REDWOOD CITY
94065-1164
United States
Telephone:
+1 (650) 2510005
Website:
https://www.nevro.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NVRO
ISIN:
US64157F1030
Market cap:
$3.26 billion
Shares in issue:
31.01 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • D.Keith Grossman
    Chairman of the Board, President, Chief Executive Officer
  • Lori Ciano
    Chief Human Resource Officer
  • Kashif Rashid
    Chief Compliance Officer, General Counsel, Secretary
  • Patrick Schmitz
    Vice President - Operations
  • Douglas Alleavitch
    Vice President - Quality and Operations
  • Christopher Christoforou
    Vice President - Research and Development
  • Niamh Pellegrini
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.